Works matching IS 20406207 AND DT 2021 AND VI 12
Results: 65
Current evidence and the emerging role of eltrombopag in severe aplastic anemia.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721998126
- By:
- Publication type:
- Article
Cytomegalovirus prophylaxis using low-dose valganciclovir in patients with acute leukemia undergoing allogeneic hematopoietic stem-cell transplantation.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721998124
- By:
- Publication type:
- Article
Bortezomib-based therapy in non-transplant multiple myeloma patients: a retrospective cohort study from the FABIO project.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721996488
- By:
- Publication type:
- Article
Current treatment options for aggressive non-Hodgkin lymphoma in elderly and frail patients: practical considerations for the hematologist.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721996484
- By:
- Publication type:
- Article
Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721994348
- By:
- Publication type:
- Article
Case report: successful perioperative management of patients with haemophilia A using an extended half-life factor VIII (Efmoroctocog alfa) during neurosurgical procedures.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721993686
- By:
- Publication type:
- Article
The role of acalabrutinib in adults with chronic lymphocytic leukemia.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721990553
- By:
- Publication type:
- Article
The evolving role of Bruton's tyrosine kinase inhibitors in chronic lymphocytic leukemia.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721989588
- By:
- Publication type:
- Article
Current and novel BTK inhibitors in Waldenström's macroglobulinemia.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721989586
- By:
- Publication type:
- Article
B-cell maturation antigen (BCMA) in multiple myeloma: the new frontier of targeted therapies.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721989585
- By:
- Publication type:
- Article
Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in diffuse large B-cell lymphoma.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721989579
- By:
- Publication type:
- Article
Relapsed/refractory multiple myeloma-transformed plasma-cell leukemia successfully treated with daratumumab followed by autologous stem cell transplantation.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721989578
- By:
- Publication type:
- Article
Hepatic venoocclusive disease/sinusoidal obstruction syndrome with normal portal vein flow mimicking aggravated chronic hepatic GVHD following inotuzumab ozogamicin salvage therapy: a case report of pathologic-radiologic discrepancy.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211066176
- By:
- Publication type:
- Article
Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211066070
- By:
- Publication type:
- Article
Prophylactic management of patients with von Willebrand disease.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211064064
- By:
- Publication type:
- Article
Association between preconditioning absolute lymphocyte count and transplant outcomes in patients undergoing matched unrelated donor allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and anti-thymocyte globulin.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211063783
- By:
- Publication type:
- Article
Daratumumab plus CyBorD for patients with newly diagnosed light chain (AL) amyloidosis.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211058334
- By:
- Publication type:
- Article
Antibiotic use and ileocolonic immune cells in patients receiving fecal microbiota transplantation for refractory intestinal GvHD: a prospective cohort study.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211058333
- By:
- Publication type:
- Article
Integration of cell therapies and bispecific antibodies into the treatment pathway of relapsed diffuse large B-cell lymphoma.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Current and emerging treatment options in primary mediastinal B-cell lymphoma.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211048959
- By:
- Publication type:
- Article
A 10-fold and greater increase in D-dimer at admission in COVID-19 patients is highly predictive of pulmonary embolism in a retrospective cohort study.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211048364
- By:
- Publication type:
- Article
Second-line administration of thrombopoietin receptor agonists in immune thrombocytopenia: Italian Delphi-based consensus recommendations.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211048361
- By:
- Publication type:
- Article
Bortezomib in autoimmune hemolytic anemia and beyond.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211046428
- By:
- Publication type:
- Article
Differential effects of donor lymphocyte infusion upon treatment response and GVHD according to relapse level and donor sources in patients with myelodysplastic syndrome.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211043748
- By:
- Publication type:
- Article
Contemporary practice patterns of tyrosine kinase inhibitor use among older patients with chronic myeloid leukemia in the United States.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211043404
- By:
- Publication type:
- Article
Challenges of biological monitoring in a hemophilia A patient without inhibitors on emicizumab undergoing major orthopedic surgery: a case report.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211040345
- By:
- Publication type:
- Article
Venetoclax combination therapy with hypomethylating agents in young adults with relapsed/refractory acute myeloid leukaemia.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211040335
- By:
- Publication type:
- Article
Ibrutinib effect in acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211039326
- By:
- Publication type:
- Article
Emicizumab in acquired haemophilia A: about two clinical cases and literature review.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211038193
- By:
- Publication type:
- Article
Addition of chemotherapy to nivolumab after PD-1 inhibitor failure as bridge to allogeneic stem cell transplantation in classical Hodgkin's lymphoma: report on three cases and literature review.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211038181
- By:
- Publication type:
- Article
Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single center retrospective study.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211035272
- By:
- Publication type:
- Article
Design of an international investigator-initiated study on MOdern Treatment of Inhibitor-positiVe pATiEnts with haemophilia A (MOTIVATE).
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211032452
- By:
- Publication type:
- Article
Clinical features of DDX41 mutation-related diseases: a systematic review with individual patient data.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211032433
- By:
- Publication type:
- Article
Case series: MRD negativity assessment using 11 C-Acetate PET with 3-weekly daratumumab-based quadruplet induction in newly diagnosed multiple myeloma.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211030369
- By:
- Publication type:
- Article
Features of indeterminate results of QuantiFERON-TB Gold In-Tube test in patients with haematological malignancies.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211028437
- By:
- Publication type:
- Article
The value of survival gains from therapeutic innovations for US patients with relapsed/refractory multiple myeloma.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211027463
- By:
- Publication type:
- Article
The use of tafasitamab in diffuse large B-cell lymphoma.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211027458
- By:
- Publication type:
- Article
CORRIGENDUM to "Should patients receive consolidation chemotherapy before reduced intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission?".
- Published in:
- 2021
- Publication type:
- Correction Notice
Natural-killer cell cytotoxicity as a diagnostic and prognostic marker for adult patients with secondary hemophagocytic lymphohistiocytosis: a prospective phase II observational study.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211020544
- By:
- Publication type:
- Article
The role of idecabtagene vicleucel in patients with heavily pretreated refractory multiple myeloma.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211019622
- By:
- Publication type:
- Article
The role of carfilzomib in relapsed/refractory multiple myeloma.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211019612
- By:
- Publication type:
- Article
Treosulfan-based conditioning for inborn errors of immunity.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211013985
- By:
- Publication type:
- Article
Ferumoxytol for the treatment of iron deficiency and iron-deficiency anemia of pregnancy.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211018042
- By:
- Publication type:
- Article
The role of axicabtagene ciloleucel as a treatment option for patients with follicular/marginal zone lymphoma.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211017788
- By:
- Publication type:
- Article
The role of tazemetostat in relapsed/refractory follicular lymphoma.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211015882
- By:
- Publication type:
- Article
Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211013987
- By:
- Publication type:
- Article
Maintenance therapy for untreated diffuse large B-cell lymphoma: a systematic review and network meta-analysis.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211018894
- By:
- Publication type:
- Article
Busulfan plus melphalan versus melphalan alone conditioning regimen after bortezomib based triplet induction chemotherapy for patients with newly diagnosed multiple myeloma.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211012985
- By:
- Publication type:
- Article
Treatment with eltrombopag of severe immune thrombocytopenia and hemolytic anemia associated with COVID-19 pneumonia: a case report.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211011353
- By:
- Publication type:
- Article
Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211010875
- By:
- Publication type:
- Article